Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Symposia No. *Symposia titles are tentative. As of April 10, 2017 Title (tentative) Role Organizer(s) Affiliation Country 1 Drug design based on 3D microstructure of receptors Organizer Yuji Ikegaya The University of Tokyo Japan 2 Alzheimer's disease: ultra-early stage diagnosis and treatment Organizer Takeshi Iwatsubo Department of Neuropathology, Graduate School of Medicine, The University of Tokyo Japan 3 Shortened life span in patients with schizophrenia: Life style related problems and clinical pharmacology of antipsychotics Organizer Kazutaka Shimoda Department of Psychiatry, Dokkyo Medical University Japan 4 Novel approaches towards understanding psychiatric disorders: inflammation in the brain and periphery Organizer Tomoyuki Furuyashiki Division of Pharmacology, Kobe University Graduate School of Medicine Japan 5 Brain-Gut Axis Organizer Ludmila Filaretova Pavlov Institute of Physiology Russia 6 Transformative technologies at the forefront of brain research Organizer Haruhiko Bito Department of Neurochemistry, Graduate School of Medicine, The University of Tokyo Japan Haruhiko Bito Department of Neurochemistry, Graduate School of Medicine, The University of Tokyo Japan Grey Stephens University of Reading UK 7 Ca2+ signaling in health and disease Organizers 8 Novel regulations and functions of dopaminergic systems towards understanding psychiatric disorders Organizer Tomoyuki Furuyashiki Division of Pharmacology, Kobe University Graduate School of Medicine Japan 9 Alpha-synuclein in Parkinson's disease Organizer Masahiro Nomoto Ehime University Japan 10 Recent advances in the development of subtype-selective and signaling-biased drugs for D2-like dopamine receptors: Organizer towards improved therapeutics for neuropsychiatric disorders David R. Sibley Molecular Neuropharmacology Section National Institute of Neurological Disorders & Stroke/NIH USA 11 Emerging therapeutic targets against autism spectrum disorder Organizer Chan Young Shin Department of Pharmacology, School of Medicine, Konkuk University Korea 12 Mechanisms of maladaptive plasticity in animal models of neuropsychiatric disorders Organizer Maurizio Popoli Department of Pharmacological and Biomolecular Sciences - University of Milano Italy Clare Stanford UCL IRIS UK Mark Tricklebank Centre for Neuroimaging Sciences, Institute of Psychiatry and Psychology and Neuroscience, UK King’s College London 13 The function and pharmacology of the neuronal reninangiotensin system Organizers 14 ADHD and Substance Use Disorders: epidemiology, neurobiology and treatment Organizer Wim van den Brink Department of Psychiatry, Academic Medical Center University of Amsterdam The Netherlands 15 Pain Sensor Organizer Yasuo Mori Graduate School of Engineering, Kyoto University Japan 16 Central Pain and Translation Organizer Fusao Kato Department of Neuroscience, Jikei University School of Medicine Japan 17 Basic and clinical pharmacology of anti-arteriosclerotic effect of anti-inflammatory drugs Hiroshi Watanabe Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Japan Medicine Organizer 18 Therapeutic strategy to enhance intrinsic resistance in cardiovascular system Organizer Motohiro Nishida Division of Cardiocirculatory Signaling Okazaki Institute for Integrative Bioscience Japan (National Institute for Physiological Sciences), National Institutes of Natural Sciences 19 New therapeutic approach for cardiorenal syndromeintegration of basic and clinical Pharmacological evidence Organizer Akira Nishiyama Department of Pharmacology, Kagawa University Medical School 20 Recent advances in the molecular and cellular understanding of heart failure --Toward novel therapeutic strategies Yasushi Fujio Laboratory of Clinical Science and Biomedicine Graduate School of Pharmaceutical Sciences, Japan Osaka University Organizer 1 Japan Symposia No. 21 22 23 *Symposia titles are tentative. Title (tentative) Hypertension: New developments in understanding and management Cutting edge of calcium permeable ion channels in diseases as potential targets of drug discovery Endothelial Mechanosensing in Vascular Physiology and Disease As of April 10, 2017 Role Organizer(s) Affiliation Country David Webb University of Edinburgh UK Bean Dhaun University of Edinburgh UK Yuji Imaizumi Graduate School of Pharmaceutical Sciences, Nagoya City University Japan David J. Beech University of Leeds UK Naoki Mochizuki National Cerebral and Cardiovascular Center Research Institute Japan Stefan Offermanns Max Planck Institute for Heart and Lung Research Germany Organizers Organizers Organizers 24 Lower Urinary Tract Dysfunction Update: New Insight into Organizer Pharmacological Mechanisms1 Hidehiro Kakizaki Department of Renal and Urologic Surgery, Asahikawa Medical University Japan 25 New pharmacological approaches for renal diseases Akira Nishiyama Department of Pharmacology, Kagawa University Medical School Japan Yukihiko Sugimoto Kumamoto University Japan Masataka Majima Department of Pharmacology, Kitasato University School of Medicine Japan Japan 26 Roles of Bioactive Lipids in Inflammatory Diseases Organizer Organizers 27 Advances in molecular targeting therapy for rheumatoid arthritis Organizer Masayoshi Harigai Division of Epidemiology and Pharmacoepidemiology, Institute of Rheumatology, Tokyo Women’s Medical University 28 Immunology and Inflammation Organizer Satoshi Uematsu Department of Mucosal Immunology, School of Medicine, Chiba University Japan Department of Immunology Graduate School of Medicine and Faculty of Medicine, The University of Tokyo Japan 29 Molecular targets and imaging studies in bone diseases Organizer Hiroshi Takayanagi 30 New Controllers of Inflammation: What are the hottest targets? Organizer Francesca Levi-Schaffer The Hebrew University of Jerusalem Israel 31 Translational Research in GI Pharmacology - Novel therapeutic strategy in GI diseases - Organizer Koji Takeuchi Japan 32 Present status and future perspective of gastric acid inhibitor Organizer Takahisa Furuta Hamamatsu University School of Medicine Kyoto Pharmaceutical University Japan 33 iPS cells and disease Organizer Haruhisa Inoue Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application Japan (CiRA), Kyoto University 34 Humanized Mouse Models and iPSC as tools to study drug toxicity Organizer Darrell R. Abernethy US Food and Drug Administration/Johns Hopkins University School of Medicine USA 35 Innovations in Overcoming Diabetes and Complications Organizer Momir Mikov Department of Pharmacology and Toxicology, University of Novi Sad Serbia 36 Role of mitochondria and oxidative stress in metabolic syndrome Organizer Julie Y.H. Chan Kaohsiung Chang Gung Memorial Hospital Taiwan 37 Novel Therapeutic Strategies for Respiratory Diseases Organizer WS Fred Wong The National University of Singapore, Yong Loo Lin School of Medicine Singapore 38 Understanding living systems by extensive analyses of all cells Organizer Hiroki R. Ueda Graduate School of Medicine, University of Tokyo/ RIKEN QBiC Japan 2 Symposia No. *Symposia titles are tentative. As of April 10, 2017 Title (tentative) Role Organizer(s) Affiliation Country 39 Systems Biology and Drug Targeting Organizer Mariko Okada Laboratory of Cell Systems, Institute for Protein Research, Osaka University Japan 40 Targeting antioxidant defence system in redox diseases Organizer Mi-Kyoung Kwak The Catholic University of Korea, College of Pharmacy Korea Ryoichiro Kageyama Kyoto University Institute for Virus Research Japan 41 Photobiology: understanding of biological systems by illuminating and controlling biological functions by light Organizers Cyril Goudet Institut de Génomique Fonctionnelle, France France 42 European & Asian training initiatives to improve safe and effective use of medicines in modern healthcare Organizer Shinichiro Ueda University of the Ryukyus Japan 43 Experiences and models for strengthening pharmacological research, teaching and services in resource strained Organizer countries Collen Masimirembwa African Institute of Biomedical Science & Technology (AiBST) Zimbabwe 44 IPE: Educating a New Generation of Healthcare Professionals to Prescribe Medications Safely and Effectively Kelly Dowhower Karpa Pennsylvania State University College of Medicine USA 45 Introducing the IUPHAR Pharmacology Education Project Organizer www.pharmacologyeducation.org John L. Szarek The Commonwealth Medical College USA 46 Frontiers in approaching retinal research - The current status and future in development of therapeutic strategies Organizer based on genetic and iPS methods- Hideaki Hara Gifu Pharmaceutical University, Molecular Pharmacology Japan 47 Novel targets and biomarkers for Anticancer Therapeutics Organizer Atsushi Ohtsu National Cancer Center Japan Japan 48 Cancer Drug Resistance Organizer Mi-Kyoung Kwak The Catholic University of Korea, College of Pharmacy Korea Japan Organizer 49 Therapeutic manipulation of RNA/DNA for genetic diseases Organizer Masatoshi Hagiwara Department of Anatomy and Developmental Biology, Kyoto University Graduate School of Medicine 50 Multidisciplinary Approach on Molecular Bio-imaging from Basic to Clinical Pharmacological Studies Organizer Kazuhiko Yanai Department of Pharmacology, Tohoku University School of Medicine Japan 51 Vaccine Drug Diagnostic Development for the control of Emerging Infectious Diseases Organizer Kouichi Morita NEKKEN, Nagasaki Univ Japan 52 All for Global Health, Global Health for All Organizer Kenji Hirayama NEKKEN、Nagasaki University Japan 53 Optimising drug selection and dosage in treating infectious Organizer diseases in children and pregnant women in Africa Lars L. Gustafsson Division of Clinical Pharmacology, Department Sweden of Laboratory Medicine, Karolinska Institutet 54 New Drugs for Emerging Infectious Disease Organizer Mauro Teixeira Department Biochemistry and Immunology, Universidade Federal de Minas Gerais Brazil 55 Globalization of Traditional Asian Medicine Organizer Haruki Yamada Kitasato University Japan 56 Ameliorating effects of traditional Chinese medicine on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage Organizer Jing-Yan Han Department of Integration of Chinese and Western Medicine, Peking University Health Science Center China 57 Pharmacological investigation in new drug discovery Organizer Guanhua Du Institute of Materia Medica, Chinese Academy China of Medical Sciences 58 Network pharmacology Organizer Wenxia Zhou Beijing Institute of Pharmacology and Toxicology 3 China Symposia No. *Symposia titles are tentative. Title (tentative) As of April 10, 2017 Role Organizer(s) Affiliation Country Japan 59 Global clinical trials and ethnic factors Organizer Masahiro Tohkin Department of Regulatory Science, Graduate School of Pharmaceutical Sciences, Nagoya City University 60 Role of database study in pharmacovigilance Organizer Kiyoshi Kubota NPO Drug Safety Research Unit Japan Japan Phil Routledge Cardiff University UK David Webb University of Edinburgh UK Daniel Antoine University of Liverpool and MRC Centre for Drug Safety Science UK 61 Health Technology Assessment (HTA) for Smaller Countries: the central role of clinical pharmacology Organizers 62 Novel biomarkers, predictors and models for drug-induced Organizer liver injury 63 Toxicogenomics for accelerated and refined hazard identification of chemicals Organizer Jun Kanno Japan Bioassay Research Center Japan Organization of Occupational Health and Japan Safety 64 Pharmacogenomics in drug therapy; future perspective, next generation of pharmacogenomics Organizer Ichiro Ieiri Kyushu University Japan 65 Posttranslational modification of nuclear receptors as therapeutic targets Organizer InKyeom Kim Kyungpook National University School of Medicine Korea 66 Pharmacogenomics in Special Populations Guilherme Suarez-Kurtz Brazilian Pharmacogenomics Network Brazil Andrew Somogyi University of Adelaide Australia Organizers 67 Horizon of PMx Organizer Yuji Kumagaya Kitasato University Hospital Clinical Trial Center Japan 68 Recent progress of immunosuppressant TDM Organizer Satohiro Masuda Department of Pharmacy, Kyushu University Hospital Japan 69 Pharmacokinetic/-dynamic modelling - Population PK/PD-models - Physiology-based PK (PBPK) models - PK/PD models: application in paediatrics - PB/PK-modelling: regulatory aspects Organizer Petra A. Thürmann University Witten/Herdecke, HELIOS Hospital Wuppertal Germany 70 The prediction of renal drug transport: a story with many tales Organizer Rosalinde Masereeuw Utrecht Institute for Pharmaceutical Sciences, The Netherlands Div. Pharmacology 71 Innovative apprach to pediatric drug development and clinical practice Topics include pharmacogenomics, pharmacometrics and new formulations. Organizer Hidefumi Nakamura National Center for Child Health and Development Japan 72 Open Innovation for Drug Discovery Organizer Chikako Saotome Department of Drug Discovery Medicine, Kyoto University Graduate School of Medicine Japan A. Mark Evans University of Edinburgh UK 73 System pharmacology of the AMPK-activated protein kinase Organizers Graham Hardie University of Dundee UK 74 Molecular pharmacology focused studies of calcium permeable ion channels: identifying new pharmacological targets and therapies Organizer Gregory Monteith The School of Pharmacy, The University of Queensland Australia 75 TBA Organizer National Doping Control Centre, Mahidol Supornchai Kongpatanakul University Thailand David Gloriam University of Copenhagen Denmark 76 Computational Pharmacology, Databases and Drug Discovery Adam Pawson University of Edinburgh UK Organizers 4 Symposia No. *Symposia titles are tentative. Title (tentative) As of April 10, 2017 Role 77 3D microtissues in drug discovery: mechanopharmacology Organizer 78 The BPS Focus on Pharmacology Project: Securing the future of Pharmacology & Clinical Pharmacology 79 Nutrient and Metabolite Sensing by GPCRs, or more broadly: Novel Natural Ligands and Functions of GPCRs Organizer(s) Affiliation Country Alastair Stewart Department of Pharmacology and Therapeutics, University of Melbourne Australia David Webb University of Edinburgh UK Jonathan Bruun British Pharmacological Society UK Kazuwa Nakao Medical Innovation Center, Kyoto University Graduate School of Medicine Japan Stefan Offermanns Max Planck Institute for Heart and Lung Research Germany Kevin Pfleger Harry Perkins Institute of Medical Research Australia Michelle Halls Monash Institute of Pharmaceutical Sciences Australia Organizers Organizers Cutting edge assay technologies for studying molecular and cellular pharmacology (joint symposium between BPS and ASCPT) Organizers 81 New insight into aquaporin function as drug targets Organizer Masato Yasui Keio University School of Medicine Japan 82 GPCR and RhoA Signaling in Physiology and Disease Organizer Joan Heller Brown Department of Pharmacology, University of California USA 83 Biased agonism at G protein-coupled receptors: The promise and the challenges Organizer Anthony P. Davenport Experimental Medicine and UK Immunotherapeutics, University of Cambridge 84 African Indigenous Biodiversity: Gateway for Discovery Organizer Douglas Oliver Pharmacology for Africa 80 5 South Africa